Skip Navigation

6th Annual Stefan S. Fajans Lecture in Diabetes, 2014-15

Steve Kahn

Steven Kahn, M.B., Ch.B.

 


 

Friday, November 7, 2014
2:00-3:30 pm
(Reception immediately following)

Oliphant-Marshall Auditorium, ground floor
Kellogg Eye Center/Brehm Tower
1000 Wall Street
Ann Arbor, MI 48105

"The Beta Cell in Type 2 Diabetes: Lessons Starting at the Bedside"

SPEAKER:
Steven E. Kahn, M.B., Ch.B.

Professor of Medicine
Division of Metabolism, Endocrinology and Nutrition
VA Puget Sound Health Care System and
University of Washington, Seattle, WA
& Director, Diabetes Research Center, University of Washington


This is the first lecture following Dr. Fajans' passing in June 2014 and will include short memorial tributes from key collaborators and colleagues. Read Dr. Fajans's obituary here.

This annual lecture in honor of Dr. Stefan S. Fajans, sponsored by the University of Michigan Division of Metabolism, Endocrinology & Diabetes, recognizes a renowned diabetes investigator and/or physician who has made significant contributions to the field.

The 2014-15 Stefan S. Fajans Lecture in Diabetes will be given by Steven E. Kahn, M.B., Ch.B., Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition at VA Puget Sound Health Care System and University of Washington, Seattle, WA, & Director of the Diabetes Research Center at the University of Washington.

Dr. Kahn’s research interests include the role of the beta cell in the pathogenesis and treatment of prediabetes and type 2 diabetes. He has performed physiological studies characterizing beta cell function in individuals with diabetes and those at increased risk and is an active participant in a number of large multicenter clinical trials in which interventions are being tested to prevent and treat type 2 diabetes. Aside from his clinical studies, Dr. Kahn has an extensive basic research program examining the role of islet amyloid in the loss of beta cells in type 2 diabetes.

Dr. Kahn has received numerous awards for his research, including the Novartis Young Investigator in Diabetes Award, American Diabetes Association Distinguished Clinical Scientist Award, The Endocrine Society Clinical Investigator Award, United States Department of Veterans Affairs John B. Barnwell Award, and European Association for the Study of Diabetes Albert Renold Award. He has been elected to membership in the American Society for Clinical Investigation and the American Association of Physicians.

More on Dr. Kahn's research

Event questions: Annette Murphy, (734) 763-3056 or amurph@umich.edu

~ ~ ~ ~ ~ ~ ~ ~


Stefan S. Fajans, M.D., former Professor Emeritus of the Department of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes, became a member of the University of Michigan Medical School faculty in 1949. He served as Chief of the Division of Endocrinology & Metabolism from 1973 to 1987 and as the Director of the NIH-funded Michigan Diabetes Research and Training Center, which he helped to found, from 1977 to 1986. Dr. Fajans devoted a large portion of his scientific career to the study of diabetes and made important contributions to the understanding of its etiology, diagnosis, and treatment, including the discovery of a genetic form of diabetes that he named MODY (Mature Onset Diabetes of the Young). For more on his work and career, please see this bio of Dr. Stefan S. Fajans [PDF].